NPI 32101 possesses both anti-inflammatory and broad spectrum antimicrobial activities. This combination of pharmacological properties may have additional therapeutic uses beyond dermatology.
- Mechanism
- Curator reviewed
NPI 32101 cream serves as a broad-spectrum antimicrobial barrier to organisms including Pseudomonas aeruginosa and Staphylococcus aureus, including strains resistant to Methicillin (MRSA). NPI 32101 has dual action against both the vegetative and spore forms of C. difficile could lead to a first-in-class drug that both treats and prevents disease recurrence.
- Primary indication
- Atopic dermatitisCurator reviewed
- Code names
- NPI 32101
Resolves to
What you can answer from here — as of April 02, 2025
Which drugs share a target with NPI 32101, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account